Evidence map›Paper›PMID 31686298›Full record

SynthesisJournal of thrombosis and thrombolysis2020

Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint.

Bernhard Wernly, Richard Rezar, Paul Gurbel, Christian Jung

Abstract readComparative StudyMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of thrombosis and thrombolysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Combining antiplatelet and anticoagulant therapy in cardiovascular disease.Hematology. American Society of Hematology. Education Program · 2020
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bernhard WernlyClinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University, Salzburg, Austria.ORCID http://orcid.org/0000-0003-4024-0220
Richard RezarClinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University, Salzburg, Austria.
Paul GurbelInova Center for Thrombosis Research and Translational Medicine, Falls Church, VA, USA.
Christian JungDivision of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University of Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany. christian.jung@med.uni-duesseldorf.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimal duration dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is subject to debate. A short-duration DAPT (one month to three months) followed by P2Y

Indexed as

HemorrhageMyocardial InfarctionPercutaneous Coronary InterventionReceptors, Purinergic P2Y12AspirinFemaleHumansMalePlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsAspirinP2RY12 protein, humanPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsReceptors, Purinergic P2Y12Acute coronary syndromeAtherosclerosisChronic coronary syndromeDAPTMeta-analysisMonotherapyP2Y12Percutaneous coronary interventionPTCA

Identifiers

PMID31686298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.